The American Heart Association's PREVENT risk calculator effectively assessed cardiovascular risk among an ethnically diverse population of 361,778 adults without diagnosed cardiovascular disease but with at least some baseline points. The risk equations performed well across Asian and Hispanic subgroups and performed better than pooled cohort equations for predicting atherosclerotic CVD across racial and ethnic groups, researchers reported in JAMA Cardiology.

Half of sudden cardiac arrests occur in individuals without a prior cardiac diagnosis, according to a study published in The Lancet. The research emphasizes the importance of public awareness, screening and the use of automated external defibrillators to improve survival rates.

A study by Johns Hopkins University showed that a lower-sodium Dietary Approaches to Stop Hypertension-style diet could significantly reduce blood pressure in patients with type 2 diabetes. Participants following the DASH for Diabetes diet saw a 4.6 mm Hg reduction in systolic blood pressure and a 2.3 mm Hg reduction in diastolic blood pressure, which lowers the risk of heart failure, stroke and cardiovascular events.

Physicians should be aware that vision loss in older adults often can be a sign of underlying cardiovascular issues. Managing blood pressure and collaborating with ophthalmologists are crucial for preventing complications.

The FDA has expanded warnings for messenger RNA-based COVID-19 vaccines to include more details about myocarditis risks, particularly for 12- to 24-year-old males. The updated label notes a risk of eight cases per 1 million people from 6 months to 64 years old who received the vaccines in 2023 or 2024. However, the CDC previously found no higher myocarditis risks associated with the vaccines since 2022, and COVID-19 itself can cause myocarditis.

HHS will be launching a campaign to encourage people to use wearable sensors that track health signs such as heart rate or blood glucose levels, HHS Secretary Robert F. Kennedy Jr. told a House subcommittee. "We're exploring ways of making sure that those costs can be paid for," Kennedy said.

Only at ASNC2025! Experts from ASNC and SCAI will participate in a timely discussion of the critical roles of PET and SPECT MPI and viability imaging in contemporary pre-revascularization decisions. Moderated by Benjamin Chow, MD, FASNC, and SCAI President-elect J. Dawn Abbott, MD, Decision Making Before Revascularization in Complex CAD: How Can Imaging Help? will address the application of nuclear imaging in CTO and multivessel disease assessment as well as cardiovascular surgeons’ imaging requirements for preoperative decision making in multivessel disease.

This ASNC/SCAI collaboration is one of 8 Heart Team sessions at ASNC2025, Sept. 4-7 in Orlando, Florida. Virtual registration available. REGISTER FOR ASNC2025.

Who will win this year’s Barry L. Zaret Young Investigator Awards Competition? Find out at ASNC2025!

Mark your calendar to attend the Sept. 6 competition. Watch as 6 early-career researchers present their work and field questions from a panel of esteemed judges as well as the audience. Two winners – one for clinical research, the other for emerging science – will receive a cash prize and an exciting addition to their CVs. MEET THE COMPETITORS.